NEW INSIGHTS IN TYPE II INFLAMMATION IN SEVERE ASTHMA
22.10.2020
Asthma is characterized by chronic inflammation of the airway.
Type 2 inflammation is present in 50%* of patients with severe asthma.
We will discuss the significant patient burden of disease and need for treatment options that address the actions of key inflammatory cytokines including IL-4, IL-5 and IL-13, which play a central role in contributing to the Type 2 inflammatory response.
* Peters MC et al. Measures of gene expression in sputum cells can identify TH2-high and TH2-low subtypes of asthma. J Allergy Clin Immunol. 2014;133(2):388–394. n=108/205
Speaker
Pr Bart Lambrecht
UZ Gent
Scientific Program
20:00 – 21:00
New Insights in Type II Inflammation in Severe Asthma
Pr Bart Lambrecht
UZ Gent
21:00 – 21:30
Q & A and conclusion
With the kind support of